Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiota and host mucosa
- Molecular classification
- Other
01
Overview
The interface between gut microbiota and host mucosa refers to the complex and dynamic interactions between the diverse community of intestinal microorganisms and the mucosal lining of the host's gastrointestinal tract. These interactions are essential for metabolic and nutritional homeostasis, immune system development, maintenance of the intestinal barrier, and defense against pathogens. Disturbances of this relationship (dysbiosis, barrier dysfunction) are implicated in multiple diseases, notably inflammatory bowel disease, metabolic disorders, and infections. There is no single molecule or receptor that represents this interface; it is a system-level target for emerging microbiota-directed and immunomodulatory therapies[1][2][3][4][5][6].
- Other names
- Gut microbiota-host interactiongut mucosal interfacemucosa-associated microbiota
02
Mechanism of action
Modulation of microbiota composition; Restoration of mucosal barrier function; Immune modulation; Inhibition or reduction of pathogen colonization
03
Biological functions
Metabolic regulationImmune system maturation and modulationMaintenance of mucosal barrier integrityHost defense against pathogensModulation of inflammationVitamin synthesis
04
Disease associations
Inflammatory bowel diseaseInfectionMetabolic diseaseImmune-mediated diseasesOther chronic inflammatory conditions
05
Safety considerations
Dysbiosis from antibioticsInfection risk with FMTVariable response to probiotics/prebioticsPotential exacerbation of immune-related diseases
06
Interacting drugs
Probiotics (e.g., Bifidobacterium, Lactobacillus)
4 more in the full profile.
07
Biomarkers
Composition of specific bacterial taxa (via 16S rRNA profiling)Mucosal gene expression (including markers of inflammation such as IL-22, IL-10, IFN-γ)Fecal IgA levels
Beyond the preview
Go deeper on Gut microbiota and host mucosa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gut microbiota and host mucosa.